NCT00351507View on ClinicalTrials.gov

A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY